store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CITCO 是一种咪唑噻唑衍生物,也是一种选择性组成型雄甾烷受体激动剂。它抑制脑肿瘤干细胞的生长和扩增,其 EC50 比孕烷 X 受体为 49 nM
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 253 | 现货 | ||
5 mg | ¥ 587 | 现货 | ||
10 mg | ¥ 912 | 现货 | ||
25 mg | ¥ 1,680 | 现货 | ||
50 mg | ¥ 2,620 | 现货 | ||
100 mg | ¥ 3,850 | 现货 | ||
200 mg | ¥ 5,490 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 646 | 现货 |
产品描述 | CITCO inhibits growth and expansion of brain tumour stem cells (BTSCs) and has an EC50 of 49 nM over pregnane X receptor (PXR), and no activity on other nuclear receptors. CITCO is an imidazothiazole derivative and it also is a selective Constitutive androstane receptor (CAR) agonist. |
体外活性 | CITCO (1-50 μM; 48?hours) results in a dose-dependent inhibition of viable cell count and proliferation in both T98G and U87MG glioma and BTSCs. CITCO (0-25?μM; 48?hours) causes the T98G and U87MG glioma and BTSCs expressing very low levels of CAR protein that increased significantly. CITCO (2.5-10?μM; 48?hours) induces apoptosis in BTSCs in culture in dose dependently, but not in normal astrocytes. CITCO (2.5, 5?μM; 48?hours) induces cell cycle arrest differentially in different BTSCs in culture, but not in normal astrocytes[1]. |
体内活性 | CITCO (intraperitoneal; 25?μg; on days 22, 24, 26, 30 and 36) results a significant decrease in tumour growth. After treatment with 100?μg CITCO, it further decreases to an undetectable level [1]. |
分子量 | 436.74 |
分子式 | C19H12Cl3N3OS |
CAS No. | 338404-52-7 |
store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: insoluble
DMSO: 11 mg/ml (25.19 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.2897 mL | 11.4485 mL | 22.8969 mL | 57.2423 mL |
5 mM | 0.4579 mL | 2.2897 mL | 4.5794 mL | 11.4485 mL | |
10 mM | 0.229 mL | 1.1448 mL | 2.2897 mL | 5.7242 mL | |
20 mM | 0.1145 mL | 0.5724 mL | 1.1448 mL | 2.8621 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
CITCO 338404-52-7 Apoptosis Others Inhibitor inhibit inhibitor